ARCHIVES

Lenalidomide Found Effective For Lymphoma In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Includes 8-page April 2002 Business & Regulatory Report.

May 3, 2002

FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science.

July 21, 2000

New Criteria For Comprehensive center Status finalized

November 17, 1989

In Brief: Michael Boyd Named New DTP Director; Saunders Retires; Michael Friedman New Chief Of CIB

October 7, 1983

DCT T Consider Reissuing RFA For Surgical Oncology

March 4, 1983

NCI Seeks to Maintain Grant Success Rate As Budget Deadlock Deepens on Capitol Hill

April 25, 2013